Nu Skin Enterprises (NUS) 10-Q7 Nov 182018 Q3 Quarterly reportFinancial data

Company Profile

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2018	Oct. 31, 2018
Entity Information [Line Items]
Entity Registrant Name	NU SKIN ENTERPRISES INC
Entity Central Index Key	1,021,561
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Ex Transition Period	false
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2018
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	Q3
Common Class A [Member]
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		55,549,288

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Current assets:
Cash and cash equivalents	$ 390,066	$ 426,399
Current investments	11,388	11,847
Accounts receivable	57,175	33,196
Inventories, net	289,291	253,454
Prepaid expenses and other	78,395	52,893
Total current assets	826,315	777,789
Property and equipment, net	496,704	464,587
Goodwill	187,423	114,954
Other intangible assets, net	91,957	67,647
Other assets	143,838	164,895
Total assets	1,746,237	1,589,872
Current liabilities:
Accounts payable	52,843	50,341
Accrued expenses	292,962	319,189
Current portion of long-term debt	82,455	77,840
Total current liabilities	428,260	447,370
Long-term debt	365,767	310,790
Other liabilities	120,076	127,116
Total liabilities	914,103	885,276
Commitments and contingencies (Note 10)
Stockholders' equity:
Class A common stock - 500 million shares authorized, $.001 par value, 90.6 million shares issued	91	91
Additional paid-in capital	545,234	466,349
Treasury stock, at cost - 34.9 million and 37.9 million shares	(1,306,012)	(1,304,694)
Accumulated other comprehensive loss	(82,555)	(66,318)
Retained earnings	1,675,376	1,609,168
Total stockholders' equity	832,134	704,596
Total liabilities and stockholders' equity	$ 1,746,237	$ 1,589,872

Consolidated Balance Sheets (_2

Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares shares in Millions	Sep. 30, 2018	Dec. 31, 2017
Stockholders' equity:
Common stock, shares authorized (in shares)	500	500
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares issued (in shares)	90.6	90.6
Treasury stock (in shares)	34.9	37.9

Consolidated Statements of Inco

Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Consolidated Statements of Income (Unaudited) [Abstract]
Revenue	$ 675,312	$ 563,698	$ 1,995,721	$ 1,612,898
Cost of sales	157,457	120,832	472,287	353,619
Gross profit	517,855	442,866	1,523,434	1,259,279
Operating expenses:
Selling expenses	271,509	235,285	801,968	672,646
General and administrative expenses	165,671	143,219	499,037	411,270
Total operating expenses	437,180	378,504	1,301,005	1,083,916
Operating income	80,675	64,362	222,429	175,363
Other income (expense), net	(6,982)	(1,172)	(16,940)	(8,470)
Income before provision for income taxes	73,693	63,190	205,489	166,893
Provision for income taxes	20,547	21,518	65,843	55,691
Net income	$ 53,146	$ 41,672	$ 139,646	$ 111,202
Net income per share (Note 2):
Basic (in dollars per share)	$ 0.96	$ 0.79	$ 2.54	$ 2.10
Diluted (in dollars per share)	$ 0.94	$ 0.76	$ 2.47	$ 2.04
Weighted-average common shares outstanding:
Basic (in shares)	55,603	52,873	55,075	52,834
Diluted (in shares)	56,704	54,834	56,539	54,519

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Consolidated Statements of Comprehensive Income (Unaudited) [Abstract]
Net income	$ 53,146	$ 41,672	$ 139,646	$ 111,202
Other comprehensive income, net of tax:
Foreign currency translation adjustment, net of taxes of $(346) and $(3,054) for the three months ended September 30, 2018 and 2017, respectively, and $(51) and $(1,376) for the nine months ended September 30, 2018 and 2017, respectively	(7,095)	5,497	(16,095)	15,273
Net unrealized gains/(losses) on foreign currency cash flow hedges, net of taxes of zero and $15 for the three months ended September 30, 2018 and 2017, respectively, and $18 and $114 for the nine months ended September 30, 2018 and 2017, respectively	0	(27)	(160)	(207)
Reclassification adjustment for realized losses/(gains) in current earnings, net of taxes of zero and $(22) for the three months ended September 30, 2018 and 2017, respectively, and $(2) and $97 for the nine months ended September 30, 2018 and 2017, respectively	0	40	18	(177)
Total other comprehensive income (loss)	(7,095)	5,510	(16,237)	14,889
Comprehensive income	$ 46,051	$ 47,182	$ 123,409	$ 126,091

Consolidated Statements of Co_2

Consolidated Statements of Comprehensive Income (Unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Other comprehensive income, net of tax:
Foreign currency translation adjustment, tax	$ (346)	$ (3,054)	$ (51)	$ (1,376)
Net unrealized gains/(losses) on foreign currency cash flow hedges, tax	0	15	18	114
Reclassification adjustment for realized losses/(gains) in current earnings, tax	$ 0	$ (22)	$ (2)	$ 97

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Cash flows from operating activities:
Net income	$ 139,646	$ 111,202
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	62,833	52,525
Equity method earnings	(456)	(655)
Gain on step acquisitions	(13,644)	0
Loss on extinguishment of debt	7,220	0
Foreign currency losses	14,960	(2,381)
Stock-based compensation	20,311	14,493
Deferred taxes	(658)	6,711
Changes in operating assets and liabilities:
Accounts receivable	(14,345)	(5,115)
Inventories, net	(26,865)	5,039
Prepaid expenses and other	(28,387)	(16,455)
Other assets	(2,150)	(3,960)
Accounts payable	(3,821)	(906)
Accrued expenses	(33,178)	(9,701)
Other liabilities	(7,616)	5,009
Net cash provided by operating activities	113,850	155,806
Cash flows from investing activities:
Purchases of property and equipment	(42,293)	(38,965)
Proceeds on investment sales	11,536	11,269
Purchases of investments	(11,420)	(8,244)
Acquisitions (net of cash acquired)	(28,311)	0
Investment in equity investee	(4,750)	(31,745)
Net cash used in investing activities	(75,238)	(67,685)
Cash flows from financing activities:
Exercise of employee stock options and taxes paid related to the net shares settlement of stock awards	8,993	16,377
Payments on long-term debt	(534,341)	(72,260)
Payment of cash dividends	(60,395)	(57,065)
Payment of debt issuance costs	(7,243)	0
Proceeds from debt	582,398	67,000
Repurchases of shares of common stock	(48,222)	(47,835)
Net cash used in financing activities	(58,810)	(93,783)
Effect of exchange rate changes on cash	(16,135)	12,185
Net increase (decrease) in cash and cash equivalents	(36,333)	6,523
Cash and cash equivalents, beginning of period	426,399	357,246
Cash and cash equivalents, end of period	$ 390,066	$ 363,769

THE COMPANY

THE COMPANY	9 Months Ended
THE COMPANY	Sep. 30, 2018
THE COMPANY [Abstract]
THE COMPANY	1. THE COMPANY Nu Skin Enterprises, Inc. (the “Company”) is a leading, global direct selling company that develops and distributes premium-quality, innovative personal care products and nutritional supplements that are sold worldwide under the Nu Skin and Pharmanex brands and a small number of other products and services. Over the last several years, the Company has introduced new Pharmanex nutritional supplements and Nu Skin personal care products under its ageLOC The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. The unaudited consolidated financial statements include the accounts of the Company and its Subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company’s financial information as of September 30, 2018, and for the three- and nine-month periods ended September 30, 2018 and 2017. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the fiscal year. The consolidated balance sheet as of December 31, 2017 has been prepared using information from the audited financial statements at that date. For further information, refer to the consolidated financial statements and accompanying footnotes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017.

NET INCOME PER SHARE

NET INCOME PER SHARE	9 Months Ended
NET INCOME PER SHARE	Sep. 30, 2018
NET INCOME PER SHARE [Abstract]
NET INCOME PER SHARE	2. NET INCOME PER SHARE Net income per share is computed based on the weighted-average number of common shares outstanding during the periods presented. Additionally, diluted earnings per share data gives effect to all potentially dilutive common shares that were outstanding during the periods presented. For the three-month periods ended September 30, 2018 and 2017, stock options of 0.5 million and 0.2 million, respectively, and for the nine-month periods ended September 30, 2018 and 2017, stock options of 0.9 million and 0.4 million, respectively, were excluded from the calculation of diluted earnings per share because they were anti-dilutive.

DIVIDENDS PER SHARE

DIVIDENDS PER SHARE	9 Months Ended
DIVIDENDS PER SHARE	Sep. 30, 2018
DIVIDENDS PER SHARE [Abstract]
DIVIDENDS PER SHARE	3. DIVIDENDS PER SHARE In February, April and July 2018, the Company’s board of directors declared a quarterly cash dividend of $0.365 per share. These quarterly cash dividends of $19.8 million, $20.3 million and $20.3 million were paid on March 14, 2018, June 13, 2018 and September 12, 2018 to stockholders of record on February 26, 2018, May 25, 2018 and August 31, 2018. In October 2018, the Company’s board of directors declared a quarterly cash dividend of $0.365 per share to be paid on December 12, 2018 to stockholders of record on November 30, 2018.

DERIVATIVE FINANCIAL INSTRUMENT

DERIVATIVE FINANCIAL INSTRUMENTS	9 Months Ended
DERIVATIVE FINANCIAL INSTRUMENTS	Sep. 30, 2018
DERIVATIVE FINANCIAL INSTRUMENTS [Abstract]
DERIVATIVE FINANCIAL INSTRUMENTS	4. DERIVATIVE FINANCIAL INSTRUMENTS The Company enters into non-designated foreign currency derivatives, primarily comprised of foreign currency forward contracts, for which hedge accounting does not apply. The changes in the fair market value of these non-designated derivatives are included in other income/expense in the Company’s consolidated statements of income. The Company uses non-designated foreign currency derivatives to hedge foreign-currency-denominated intercompany transactions and to partially mitigate the impact of foreign-currency fluctuations. The fair value of the non-designated foreign currency derivatives is based on third-party quotes. The following table summarizes gains (losses) related to derivative instruments not designated as hedging instruments during the three- and nine-month periods ended September 30, 2018 and 2017 (U.S. dollars in thousands): Derivatives not designated as hedging instruments: Location of Gain (Loss) Recognized in Income Amount of Gain (Loss) Recognized in Income Three Months Ended September 30, Nine Months Ended September 30, 2018 2017 2018 2017 Foreign currency contracts Other income (expense) $ — $ — $ — $ (485 ) The Company designates as cash-flow hedges those foreign currency forward contracts it enters to hedge forecasted intercompany transactions that are subject to foreign currency exposures. Changes in the fair value of these forward contracts designated as cash-flow hedges are recorded as a component of accumulated other comprehensive loss within shareholders’ equity (deficit), and are recognized in the consolidated statement of income during the period which approximates the time the hedged transaction is settled. As of September 30, 2018, the Company held no forward contracts designated as foreign currency cash flow hedges compared to notional amounts of 1.4 billion Japanese yen ($12.4 million) as of September 30, 2017, to hedge forecasted foreign-currency-denominated intercompany transactions. The fair value of these hedges were zero and $0.3 million as of September 30, 2018 and 2017, respectively. The following table summarizes gains (losses) related to derivative instruments recorded in other comprehensive income (loss) during the three- and nine-month periods ended September 30, 2018 and 2017 (U.S. dollars in thousands): Derivatives designated as hedging instruments: Amount of Gain (Loss) Recognized in Other Comprehensive Loss Three Months Ended September 30, Nine Months Ended September 30, 2018 2017 2018 2017 Foreign currency forward contracts $ — $ (27 ) $ (160 ) $ (207 ) The following table summarizes gains (losses) relating to derivative instruments reclassified from accumulated other comprehensive loss into income during the three- and nine-month periods ended September 30, 2018 and 2017 (U.S. dollars in thousands): Derivatives designated as hedging instruments: Location of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income Three Months Ended September 30, Nine Months Ended September 30, 2018 2017 2018 2017 Foreign currency forward contracts related to intercompany license fees and product sales hedges Revenue $ — $ (67 ) $ 18 $ 42 Foreign currency forward contracts related to intercompany selling expense hedges Selling expenses $ — $ 5 $ — $ 233 As of September 30, 2018 and December 31, 2017, there were zero and $0.1 million, respectively, of unrealized gains/(losses) included in accumulated other comprehensive loss related to foreign currency cash flow hedges. The remaining $82.6 million and $66.4 million as of September 30, 2018 and December 31, 2017, respectively, in accumulated other comprehensive loss are related to cumulative translation adjustments. The Company assesses hedge effectiveness at least quarterly. During the three- and nine- month periods ended September 30, 2018 and 2017, all hedges were determined to be effective. The Company reports its derivatives at fair value as either other current assets or accrued expenses within its consolidated balance sheet. See Note 12 - Fair Value.

REPURCHASES OF COMMON STOCK

REPURCHASES OF COMMON STOCK	9 Months Ended
REPURCHASES OF COMMON STOCK	Sep. 30, 2018
REPURCHASES OF COMMON STOCK [Abstract]
REPURCHASES OF COMMON STOCK	5. REPURCHASES OF COMMON STOCK During the three-month periods ended September 30, 2018 and 2017, the Company repurchased 0.2 million and 0.4 million shares of its Class A common stock under its open market stock repurchase plans for $12.4 million and $25.7 million, respectively. During the nine-month periods ended September 30, 2018 and September 30, 2017, the Company repurchased 0.6 million and 0.8 million shares of its Class A common stock under its open market repurchase plans for $48.2 million and $47.8 million, respectively. In July 2018, the previous stock repurchase plan was terminated and replaced by a new repurchase plan with an initial authorization amount of $500 million. As of September 30, 2018, $492.4 million was available for repurchases under the Company’s open market stock repurchase plan.

SEGMENT INFORMATION

SEGMENT INFORMATION	9 Months Ended
SEGMENT INFORMATION	Sep. 30, 2018
SEGMENT INFORMATION [Abstract]
SEGMENT INFORMATION	6. SEGMENT INFORMATION As a result of the Company’s management changes in the first quarter of 2017, the Company concluded that the Chief Operating Decision Maker, as defined in ASC 280, is now comprised of the CEO, President, and CFO. This change required the Company to reevaluate its determination of operating segments. The Company’s operating segments are based on geographic regions that generate revenue and hold its long-lived assets. The Company sells and distributes its products through a global network of customers and sales leaders in approximately 50 markets. The Company has divided these markets into seven operating segments, which are the Company’s reportable segments: Mainland China, Hong Kong/Taiwan, South Korea, Japan, Southeast Asia, Americas/Pacific and EMEA. The reportable segments generate revenue from the sale of personal care products and nutritional supplements under the Nu Skin and Pharmanex brands, have similar business characteristics and align with how the CODM function began assessing performance and allocating resources in the first quarter of 2017. The Other category includes the manufacturing and product-packaging companies that the Company acquired during the first quarter of 2018. Segment information for the three- and nine-month periods ended September 30, 2017 has been recast to reflect the move of the Pacific components from the "Southeast Asia/Pacific" operating segment to the "Americas/Pacific" operating segment. Consolidated financial information is not affected. Profitability by segment as determined under US GAAP is driven primarily by the Company’s transfer pricing policies. Segment contribution, which is the Company’s segment profitability metric presented in the table below, excludes certain intercompany charges, specifically royalties, license fees, transfer pricing, discrete charges and other miscellaneous items. These charges have been included in Corporate and other expenses. Corporate and other expenses also include costs related to the Company’s executive and administrative offices, information technology, research and development, and marketing and supply chain functions not recorded at the segment level. The accounting policies of the segments are the same as those described in Note 1 – The Company. The Company evaluates the performance of its segments based on revenue and segment contribution. Each segment records direct expenses related to its employees and its operations. Summarized financial information for the Company’s reportable segments is shown in the following tables. Asset information is not reviewed or included with the Company’s internal management reporting. Therefore, the Company has not disclosed asset information for each reportable segment. Revenue by Segment Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2018 2017 2018 2017 Mainland China $ 226,645 $ 172,556 $ 669,432 $ 494,658 Americas/Pacific 93,580 85,672 289,859 240,094 South Korea 89,963 89,238 270,517 258,626 Southeast Asia 86,307 71,141 236,390 194,711 Japan 63,649 62,513 190,986 188,465 Hong Kong/Taiwan 44,949 41,050 138,147 120,069 EMEA 42,819 40,133 131,810 112,385 Other 27,400 1,395 68,580 3,890 Total $ 675,312 $ 563,698 $ 1,995,721 $ 1,612,898 Segment Contribution Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2018 2017 2018 2017 Mainland China $ 71,185 $ 42,375 $ 189,901 $ 130,085 Americas/Pacific 11,848 14,106 38,088 37,884 South Korea 24,754 23,713 75,836 70,503 Southeast Asia 21,204 17,380 58,245 43,763 Japan 15,162 12,786 41,777 36,134 Hong Kong/Taiwan 8,100 8,096 23,781 20,945 EMEA 2,614 2,896 10,438 8,304 Total segment contribution 154,867 121,352 438,066 347,618 Corporate and other (74,192 ) (56,990 ) (215,637 ) (172,255 ) Operating income 80,675 64,362 222,429 175,363 Other income (expense) (6,982 ) (1,172 ) (16,940 ) (8,470 ) Income before provision for income taxes $ 73,693 $ 63,190 $ 205,489 $ 166,893 Depreciation and Amortization Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2018 2017 2018 2017 Mainland China $ 3,132 $ 3,550 $ 10,063 $ 11,202 Americas/Pacific 229 375 722 1,425 South Korea 1,421 1,586 4,664 4,872 Southeast Asia 525 551 1,648 1,628 Japan 873 898 2,688 2,677 Hong Kong/Taiwan 279 353 923 999 EMEA 238 226 589 820 Other 15,994 9,906 41,536 28,902 Total $ 22,691 $ 17,455 $ 62,833 $ 52,525 Capital Expenditures Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2018 2017 2018 2017 Mainland China $ 2,117 $ 688 $ 5,015 $ 2,351 Americas/Pacific 223 136 652 697 South Korea 135 — 179 464 Southeast Asia 357 281 552 814 Japan 125 109 508 206 Hong Kong/Taiwan 31 2 629 1,119 EMEA 348 571 425 882 Other 10,528 9,427 34,333 32,432 Total $ 13,864 $ 11,214 $ 42,293 $ 38,965 Revenue by Major Market A major market is defined as one with total revenue greater than 10% of consolidated total revenue. Based on this criteria, the Company has identified three major markets: Mainland China, South Korea and Japan. There are approximately 50 other markets, each of which individually is less than 10%. No single customer accounted for 10% or more of net sales for the periods presented. Sales are recorded in the jurisdiction in which the transactions occurred. Revenue by Product Line Three Months Ended September 30, Nine Months Ended September 30, 2018 2017 2018 2017 Nu Skin $ 384,635 $ 338,305 $ 1,237,547 $ 985,465 Pharmanex 261,892 224,031 687,789 623,046 Other 28,785 1,362 70,385 4,387 Totals $ 675,312 $ 563,698 $ 1,995,721 $ 1,612,898 Long-Lived Assets by Major Market A major market is defined as a market with long-lived assets greater than 10% of consolidated long-lived assets and also includes the Company’s country of domicile (the U.S.). Long-lived assets in Mainland China consist primarily of property, plant and equipment related to manufacturing, distribution facilities and the Mainland China headquarters. Long-lived assets in the U.S. consist primarily of property, plant and equipment, including the Company’s corporate offices and distribution facilities. Long-lived assets by major markets are set forth below for the periods ended September 30, 2018 and December 31, 2017 (U.S. dollars in thousands): September 30, 2018 December 31, 2017 United States $ 357,426 $ 302,884 Mainland China 84,680 97,046 South Korea 36,609 42,211 Japan 7,195 9,342 All others 10,794 13,104 Total $ 496,704 $ 464,587

GOODWILL

GOODWILL	9 Months Ended
GOODWILL	Sep. 30, 2018
GOODWILL [Abstract]
GOODWILL	7. GOODWILL During the first quarter of 2017, the Company realigned its operational segments and reporting structure to reflect how the business will be managed going forward. As part of this realignment, the Company divided its single operating segment into seven geographical reporting segments. The Company’s reporting units for goodwill are its operating segments, which are also its reportable segments. As a result of the segment changes, the historical goodwill of $115.0 million was allocated to the seven reportable segments. The following table presents goodwill allocated to the Company’s reportable segments for the periods ended September 30, 2018 and December 31, 2017 (U.S. dollars in thousands): September 30, 2018 December 31, 2017 Mainland China $ 32,179 $ 32,179 Americas/Pacific 9,449 9,449 South Korea 29,261 29,261 Southeast Asia 18,537 18,537 Japan 16,019 16,019 Hong Kong/Taiwan 6,634 6,634 EMEA 2,875 2,875 Other 72,469 — Total $ 187,423 $ 114,954 The Other category represents goodwill allocated to the companies acquired in the first quarter of 2018 (see Note 15 – Acquisitions).

INVENTORY

INVENTORY	9 Months Ended
INVENTORY	Sep. 30, 2018
INVENTORY [Abstract]
INVENTORY	8. INVENTORY Inventories consist of the following (U.S. dollars in thousands): September 30, 2018 December 31, 2017 Raw materials $ 89,830 $ 87,683 Finished goods 199,461 165,771 $ 289,291 $ 253,454 The total inventory balance as of September 30, 2018 includes $23.3 million of inventory held by the companies acquired in the first quarter of 2018 (see Note 15 - Acquisitions).

INCOME TAXES

INCOME TAXES	9 Months Ended
INCOME TAXES	Sep. 30, 2018
INCOME TAXES [Abstract]
INCOME TAXES	9. INCOME TAXES Provision for income taxes for the three- and nine-month periods of 2018 was $20.5 million and $65.8 The Company accounts for income taxes in accordance with the Income Taxes Topic of the Financial Accounting Standards Codification. These standards establish financial accounting and reporting standards for the effects of income taxes that result from an enterprise’s activities during the current and preceding years. The Company takes an asset and liability approach for financial accounting and reporting of income taxes. The Company pays income taxes in many foreign jurisdictions based on the profits realized in those jurisdictions, which can be significantly impacted by terms of intercompany transactions between the Company and its foreign affiliates. Deferred tax assets and liabilities are created in this process. The Company has netted these deferred tax assets and deferred tax liabilities by jurisdiction. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be ultimately realized. The Company had net deferred tax assets of $5.4 million and net deferred tax liabilities of $2.9 million as of September 30, 2018 and December 31, 2017, respectively. In accordance with ASU 2018-05 and SAB 118, the Company recognized the provisional tax impacts related to the re-measurement of our deferred income tax assets and liabilities and the one-time, mandatory transition tax on deemed repatriation during the year ended December 31, 2017. As of September 30, 2018, the Company has not made any additional measurement-period adjustments related to these items. Such adjustments may be necessary in future periods due to, among other things, the significant complexity of the Act and anticipated additional regulatory guidance that may be issued by the Internal Revenue Service (“IRS”), changes in analysis, interpretations and assumptions the Company has made and actions the Company may take as a result of the Act. The Company is continuing to gather information to assess the application of the Act and expects to complete its analysis by December 2018. The Company files income tax returns in the U.S. federal jurisdiction, and in various state and foreign jurisdictions. The Company is no longer subject to tax examinations from the IRS for all years for which tax returns have been filed before 2011. With a few exceptions, the Company is no longer subject to state and local income tax examination by tax authorities for the years before 2011. In 2009, the Company entered into a voluntary program with the IRS called Compliance Assurance Process (“CAP”). The objective of CAP is to contemporaneously work with the IRS to achieve federal tax compliance and resolve all or most of the issues prior to filing of the tax return. The Company has elected to participate in the CAP program for 2018 and may elect to continue participating in CAP for future tax years; the Company may withdraw from the program at any time. In major foreign jurisdictions, the Company is generally no longer subject to income tax examinations for years before 2011. However, statutes in certain countries may be as long as ten years. Along with the IRS examination of 2011, the Company is currently under examination in certain foreign jurisdictions; however, the outcomes of those reviews are not yet determinable. In the first quarter of 2018 there was a discrete income tax charge of $5.8 million booked. The charge was primarily related to additional reserves as the result of an Income Tax audit in Indonesia. The Company's unrecognized tax benefits relate to multiple jurisdictions. Due to potential increases in unrecognized tax benefits from the multiple jurisdictions in which the Company operates, as well as the expiration of various statutes of limitation, it is reasonably possible that the Company's gross unrecognized tax benefits, net of foreign currency adjustments, may decrease within the next 12 months by a range of approximately $0.1 to $1 million.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
COMMITMENTS AND CONTINGENCIES	Sep. 30, 2018
COMMITMENTS AND CONTINGENCIES [Abstract]
COMMITMENTS AND CONTINGENCIES	10. COMMITMENTS AND CONTINGENCIES The Company is subject to government regulations pertaining to product formulation, labeling and packaging, product claims and advertising, and the Company's direct selling system. The Company is also subject to the jurisdiction of numerous foreign tax and customs authorities. Any assertions or determination that either the Company or the Company's sales force is not in compliance with existing statutes, laws, rules or regulations could have a material adverse effect on the Company's operations. In addition, in any country or jurisdiction, the adoption of new statutes, laws, rules or regulations or changes in the interpretation of existing statutes, laws, rules or regulations could have a material adverse effect on the Company and its operations. No assurance can be given that the Company's compliance with applicable statutes, laws, rules and regulations will not be challenged by foreign authorities or that such challenges will not have a material adverse effect on the Company's financial position, results of operations or cash flows. The Company and its Subsidiaries are defendants in litigation, investigations and other proceedings involving various matters. In the opinion of the Company's management, based upon advice of its counsel handling such litigation, investigations and other proceedings, adverse outcomes, if any, are not currently expected to result in a material effect on the Company's consolidated financial condition, results of operations or cash flows. The Company is subject to regular audits by federal, state and foreign tax authorities. These audits may result in additional tax liabilities. The Company believes it has appropriately provided for income taxes for all years. Several factors drive the calculation of its tax reserves. Some of these factors include: (i) the expiration of various statutes of limitations; (ii) changes in tax law and regulations; (iii) issuance of tax rulings; and (iv) settlements with tax authorities. Changes in any of these factors may result in adjustments to the Company's reserves, which would impact its reported financial results.

DEBT

DEBT	9 Months Ended
DEBT	Sep. 30, 2018
DEBT [Abstract]
DEBT	11. DEBT Existing Credit Agreement On October 9, 2014, the Company entered into a Credit Agreement (the “Existing Credit Agreement”) with various financial institutions, and Bank of America, N.A. as administrative agent. The Existing Credit Agreement provided for a $127.5 million term loan facility, a 6.6 billion Japanese yen term loan facility and a $187.5 million revolving credit facility, each with a term of five years. On October 10, 2014, the Company drew the full amount of the term loan facilities. On April 18, 2018, the Company repaid the full balance that was outstanding under the Existing Credit Agreement. As of September 30, 2018 and December 31, 2017, the Company had an outstanding balance of zero and $47.5 million, respectively, on the revolving credit facility. The Existing Credit Agreement required that the Company maintain a consolidated leverage ratio not exceeding 2.25 to 1.00 and a consolidated interest coverage ratio of no less than 3.00 to 1.00. New Credit Agreement On April 18, 2018, the Company entered into a Credit Agreement (the “New Credit Agreement”) with several financial institutions as lenders and Bank of America, N.A., as administrative agent. The New Credit Agreement provides for a $400 million term loan facility and a $350 million revolving credit facility, each with a term of five years. Concurrently with the closing of the New Credit Agreement, the Company drew the full amount of the term loan facility and $78.5 million of the revolving facility, each of which initially bear interest at the London Interbank Offered Rate (“LIBOR”), plus 2.25%. The interest rate applicable to the facilities is subject to adjustment based on the Company’s consolidated leverage ratio. The term loan facility will amortize in quarterly installments in amounts resulting in an annual amortization of 5.0% during the first and second years, 7.5% during the third and fourth years and 10.0% during the fifth year after the closing date of the New Credit Agreement, with the remainder payable at final maturity. The New Credit Agreement requires the Company to maintain a consolidated leverage ratio not exceeding 2.25 to 1.00 and a consolidated interest coverage ratio of no less than 3.00 to 1.00. Convertible Note On June 16, 2016, the Company issued $210.0 million of convertible senior notes (the “Convertible Notes”) in a private offering to a Chinese investor (the “Holder”). The Convertible Notes were senior unsecured obligations which ranked equal in right of payment to all senior unsecured indebtedness of the Company and ranked senior in right of payment to any indebtedness that was contractually subordinated to the Convertible Notes. Interest on the Convertible Notes was payable semiannually in arrears on June 15 and December 15 of each year at a rate of 4.75% per annum. The Convertible Notes had a stated maturity date of June 15, 2020, unless repurchased or converted prior to maturity. Prior to the stated maturity date, the Company could, at its option, redeem all or part of the Convertible Notes at a price equal to 100% of the principal amount thereof, plus accrued and unpaid interest, if any, provided that its common stock share price was equal to or exceeded 180% of the applicable conversion price for 20 or more trading days (including the final three trading days) in the 30 consecutive trading days prior to the Company’s exercise of such redemption right. The Holder of the Convertible Notes could, at its option, cause the Company to repurchase all of such Holder’s Convertible Notes or any portion thereof that was equal to $1,000 in principal amount or multiples of $1,000 upon a change in control or a termination of trading of the Company’s common stock, as those terms were defined in the indenture governing the Convertible Notes. In addition, the Holder of the Convertible Notes had the right, at such Holder’s option, to convert all or any portion thereof that is equal to $1,000 in principal amount or multiples of $1,000 at any time beginning six calendar months following June 16, 2016, at the then-applicable conversion rate. Upon conversion by the Holder, the Convertible Notes would be settled in cash with respect to principal and any accrued and unpaid interest to such date and in the Company’s common shares with respect to any additional amounts, based on the applicable conversion rate at such time. The Convertible Notes had an initial conversion rate of 21.5054 common shares per $1,000 principal amount of the Convertible Notes (which is equal to an initial conversion price of approximately $46.50 per common share). Throughout the term of the Convertible Notes, the conversion rate could be adjusted upon the occurrence of certain specified events. Of the $210.0 million in proceeds received from the issuance of the Convertible Notes, $199.1 million was originally allocated to long-term debt (the “Liability Component”) and $10.9 million was allocated to additional paid-in capital (the “Equity Component”) within the Company’s consolidated balance sheet. The Liability Component was calculated by measuring the fair value of a similar debt instrument that does not have an associated conversion feature. The amount allocated to the Equity Component, representing the conversion option, was calculated by deducting the fair value of the Liability Component from the par value of the Convertible Notes. The Company determined that the conversion option did not require separate accounting treatment as a derivative instrument because it was both indexed to the Company’s own stock and would be classified in stockholders’ equity if freestanding. The Equity Component would not be remeasured as long as it continued to meet the conditions for equity classification. The excess of the principal amount of the Liability Component over its carrying amount (the “Debt Discount”) was amortized to interest expense over the term of the Convertible Notes. As a result, the Liability Component was accreted up to the Convertible Notes’ $210.0 million face value, resulting in additional non-cash interest expense being recognized within the Company’s consolidated statement of income. The effective interest rate on the Convertible Notes was approximately 7.1% per annum. The Company incurred approximately $6.6 million of issuance costs related to the issuance of the Convertible Notes. Of the $6.6 million in issuance costs incurred, $6.3 million and $0.3 million were recorded to deferred financing cost and additional paid-in capital, respectively, in proportion to the allocation of the proceeds of the Convertible Notes. The $6.3 million recorded to deferred financing cost on the Company’s consolidated balance sheet as a reduction of long-term debt was amortized over the contractual term of the Convertible Notes using the effective interest method. During the first quarter of 2018 the issuance costs were expensed due to the conversion of the Notes. During the three- and nine-months ended September 30, 2018, the Company recognized zero and $3.5 million, respectively in interest expense related to the Convertible Notes, which included zero and $3.0 million, respectively of contractual interest and zero and 0.5 million, respectively in amortization of debt issuance costs and in amortization of the Debt Discount prior to the conversion of the Notes. During the first quarter of 2018, the Holder elected to convert the Convertible Notes pursuant to their terms in the indenture. The Company satisfied the equity portion of its conversion obligation on February 28, 2018 by issuing 1,535,652 shares of the Company’s Class A Common Stock to the Holder and, on April 18, 2018, satisfied and discharged its obligations under the Convertible Notes and the indenture governing the Convertible Notes by paying the Holder $213.4 million which included $3.4 million of accrued interest from December 15, 2017 through April 17, 2018. The early conversion of the notes resulted in a $7.2 million charge to other income (expense) during the first quarter of 2018 for a loss on extinguishment of debt. The following table summarizes the Company’s debt facilities as of September 30, 2018 and December 31, 2017: Facility or Arrangement Original Principal Amount Balance as of September 30, 2018 (1)(2) Balance as of December 31, 2017 (2) Interest Rate Repayment terms October 2014 Credit Agreement term loan facility: U.S. dollar denominated: $127.5 million — $94.8 million Variable 30 day: 4.627% Principal amount was paid in full during April 2018. Japanese yen denominated: 6.6 billion yen — 4.9 billion yen ($43.5 million as of December 31, 2017) Variable 30 day: 2.7595% Principal amount was paid in full during April 2018. October 2014 Credit Agreement revolving credit facility: — $47.5 million Variable 30 day: 4.594% Principal amount was paid in full during April 2018 and credit line was closed. April 2018 Credit Agreement term loan facility: U.S. dollar denominated: $400.0 million $390.0 million — Variable 30 day: 4.49% 35% of the principal amount is payable in increasing quarterly installments over a five-year period that began on June 30, 2018, with the remainder payable at the end of the five-year term. April 2018 Credit Agreement revolving credit facility: $62.5 million — Variable 30 day: 4.49% Revolving line of credit expires April 18, 2023. Japan subsidiary loan: 2.1 billion yen — 0.7 billion yen ($5.9 million as of December 31, 2017) 0.66% Principal amount was paid in full during July 2018. Convertible note: $210.0 million — $210.0 million 4.75% Principal amount was paid in full during April 2018. (1) As of September 30, 2018, the current portion of the Company’s debt (i.e. becoming due in the next 12 months) included $20.0 million of the balance of its U.S. dollar denominated debt under the New Credit Agreement facility. The Company has classified the $62.5 million borrowed under the revolving line of credit as short-term debt because it is the Company’s intention to use the line of credit to borrow and pay back funds over short periods of time. (2) The carrying value of the debt reflects the amounts stated in the above table less debt issuance costs of $4.2 million as of September 30, 2018 related to the credit agreement; and a debt discount of $9.1 million and debt issuance costs of $4.0 million (consisting of $11.1 million related to the Convertible Note and $2.0 million related to the credit agreement) as of December 31, 2017, which is not reflected in this table.

FAIR VALUE

FAIR VALUE	9 Months Ended
FAIR VALUE	Sep. 30, 2018
FAIR VALUE [Abstract]
FAIR VALUE	12. FAIR VALUE The carrying value of financial instruments including cash and cash equivalents, accounts receivable and accounts payable approximate fair values due to the short-term nature of these instruments. The Company’s current investments as of September 30, 2018 include certificates of deposits and pre-refunded municipal bonds that are classified by management as held-to-maturity as the Company had the positive intent and ability to hold to maturity. The carrying value of these current investments approximate fair values due to the short-term nature of these instruments. The Company has classified these instruments as Level 2 in the fair value hierarchy. Fair value estimates are made at a specific point in time, based on relevant market information. The FASB Codification defines fair value as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. On a quarterly basis, the Company measures at fair value certain financial assets, including cash equivalents. Accounting standards specify a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. These two types of inputs have created the following fair-value hierarchy: ▪ Level 1 – quoted prices in active markets for identical assets or liabilities; ▪ Level 2 – inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; ▪ Level 3 – unobservable inputs based on the Company’s own assumptions. Accounting standards permit companies, at their option, to measure certain financial instruments and other eligible items at fair value. The Company has elected not to apply the fair value option to existing eligible items beyond what is required by US GAAP. The following tables present the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis (U.S. dollars in thousands): Fair Value at September 30, 2018 Level 1 Level 2 Level 3 Total Financial assets (liabilities): Cash equivalents and current investments $ 38,282 $ — $ — $ 38,282 Other long-term assets 3,582 — — 3,582 Forward contracts — — — — Life insurance contracts — — 39,248 39,248 Total $ 41,864 $ — $ 39,248 $ 81,112 Fair Value at December 31, 2017 Level 1 Level 2 Level 3 Total Financial assets (liabilities): Cash equivalents and current investments $ 36,531 $ — $ — $ 36,531 Other long-term assets 3,726 — — 3,726 Forward contracts — 158 — 158 Life insurance contracts — — 37,737 37,737 Total $ 40,257 $ 158 $ 37,737 $ 78,152 The following table provides a summary of changes in fair value of the Company’s Level 3 marketable securities (U.S. dollars in thousands): Life Insurance Contracts Beginning balance at January 1, 2018 $ 37,737 Actual return on plan assets 1,746 Purchases and issuances — Sales and settlements (235 ) Transfers into Level 3 — Ending balance at September 30, 2018 $ 39,248

ACCOUNTING PRONOUNCEMENTS

ACCOUNTING PRONOUNCEMENTS	9 Months Ended
ACCOUNTING PRONOUNCEMENTS	Sep. 30, 2018
ACCOUNTING PRONOUNCEMENTS [Abstract]
ACCOUNTING PRONOUNCEMENTS	13. ACCOUNTING PRONOUNCEMENTS In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606) In February 2016, the FASB issued ASU 2016-02, Leases (Subtopic 842) , but we do not expect a material impact on the Consolidated Statements of Income or Consolidated Statements of Cash Flows. In March 2016, the FASB issued ASU 2016-09, Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting In the second half of 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments Statement of Cash Flows (Topic 230): Restricted Cash. In January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a In January 2017, the FASB issued ASU 2017-04, Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment . This guidance simplifies the required test of goodwill for impairment by eliminating Step 2 from the goodwill impairment test. If a company determines in Step 1 of the goodwill impairment test that the carrying value of a reporting unit is less than the fair value, an impairment in that amount should be recorded to the income statement, rather than proceeding to Step 2. This ASU is effective for interim and annual impairment tests in fiscal years beginning after December 15, 2019. Early adoption is permitted. The adoption of this guidance is not expected to have a material impact on the Company’s consolidated financial statements. In December 2017, the FASB issued ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities The In February 2018, the FASB issued ASU 2018-02, Income Statement – Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. modifies, removes, and adds certain disclosure requirements on fair value measurements.

COST OF SALES

COST OF SALES	9 Months Ended
COST OF SALES	Sep. 30, 2018
COST OF SALES [Abstract]
COST OF SALES	14. COST OF SALES The Tokyo District Court and, on appeal in 2017, the Tokyo High Court upheld the Japan customs authorities' customs assessments related to the importation of several of the Company's products into Japan. The Company appealed the High Court's decision to the Japan Supreme Court. In May 2018, the Japan Supreme Court declined to hear the Company’s appeal. Accordingly, this matter is now closed. As previously disclosed, the Company already recorded a charge of $31.4 million to cost of sales in the first quarter of 2016, when the District Court issued its decision. This charge represents the full amount being disputed. It was a non-cash item because the Company was previously required to pay the assessments.

ACQUISITIONS

ACQUISITIONS	9 Months Ended
ACQUISITIONS	Sep. 30, 2018
ACQUISITIONS [Abstract]
ACQUISITIONS	15. ACQUISITIONS On January 22, 2018, the Company acquired the remaining 73% ownership in Innuvate Health Sciences, LLC ("Innuvate"), which owns a 92% interest in a nutritional product manufacturer. Prior to this acquisition, the Company owned 27% of Innuvate and accounted for it using the equity method. The remaining 8% ownership in the manufacturer will continue to be held by an unrelated third party. Under the terms of the agreement, the Company paid $23.5 million in cash and shares of the Company in exchange for the 73% ownership in Innuvate, subject to adjustment for certain closing items. Innuvate is a contract manufacturer that specializes in softgel and hardshell capsule manufacturing. On February 12, 2018, the Company acquired the remaining 65% ownership in Treviso, LLC ("Treviso"), making Treviso a wholly owned subsidiary of the Company. Treviso is a personal care product manufacturer. Prior to this acquisition, the Company owned 35% of Treviso and accounted for it using the equity method. Under the terms of the purchase agreement, the Company has paid $83.9 million in cash and shares of the Company in exchange for the 65% ownership in Treviso, subject to adjustment for certain closing items. Treviso is a liquid contract manufacturing laboratory for premium personal care products. On February 12, 2018, the Company acquired 100% ownership in L&W Holdings, Inc. ("L&W") making L&W a wholly owned subsidiary of the Company. L&W is a packaging supplier company. Under the terms of the purchase agreement, the Company paid $25.0 million in shares of the Company in exchange for 100% ownership in L&W, subject to adjustment for certain closing items. L&W specializes in the distribution and packaging of products in the cosmetic and nutritional industries. The following table summarizes the fair value of consideration transferred for the acquisitions disclosed above (in thousands): Innuvate Treviso L&W Holdings Total Total cash consideration $ 17,587 $ 14,648 $ — $ 32,235 Shares issued in conjunction with acquisition 5,863 69,252 25,000 100,115 Total consideration $ 23,450 $ 83,900 $ 25,000 132,350 Previously held equity interest in equity method Investments (1) 8,748 30,281 — 39,029 Total $ 32,198 $ 114,181 $ 25,000 $ 171,379 (1) The acquisitions of Innuvate and Treviso are considered step acquisitions, and accordingly, the Company remeasured its pre-existing 27% equity interest in Innuvate and 35% of Treviso immediately prior to completion of the acquisition to its estimated fair value of approximately $39.0 million. As a result of the remeasurement, the Company recorded a gain of approximately $13.6 million within other income (expense), during the first quarter of 2018, representing the excess of the approximate $39.0 million estimated fair value of its pre-existing 27% equity interest in Innuvate and 35% equity interest of Treviso over its transaction date carrying value of approximately $25.4 million. The following table summarizes the fair value of the assets acquired for the acquisitions disclosed above (in thousands): Innuvate Treviso L&W Holdings Life Amount Life Amount Life Amount Total current assets $ 6,219 $ 19,659 $ 7,353 Fixed assets 9,291 33,282 114 Customer list 9 years 5,100 9 years 16,500 7 years 6,500 Order backlog 5 months 200 10 months 4,700 4 months 900 Trademarks 7 years 900 6 years 1,300 5 years 600 Total current liabilities (3,942 ) (3,740 ) (1,495 ) Other non-current liabilities — — (1,731 ) Total identifiable net assets acquired 17,768 71,701 12,241 Goodwill 17,230 42,480 12,759 Fair value of noncontrolling interest (2,800 ) — — Total consideration and value to be allocated to net assets $ 32,198 $ 114,181 $ 25,000 Pro forma and historical results of operations for the acquired companies have not been presented because they are not material, either individually or in the aggregate, to the company’s consolidated financial statements.

REVENUE RECOGNITION

REVENUE RECOGNITION	9 Months Ended
REVENUE RECOGNITION	Sep. 30, 2018
REVENUE RECOGNITION [Abstract]
REVENUE RECOGNITION	16. REVENUE RECOGNITION Adoption of ASC Topic 606, "Revenue from Contracts with Customers" On January 1, 2018, the Company adopted Topic 606 using the modified retrospective method applied to those contracts which were not completed as of January 1, 2018. Results for reporting periods beginning after January 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with our historic accounting under Topic 605. The Company recorded a net reduction to opening retained earnings of $11.2 million, net of tax, as of January 1, 2018 due to the cumulative impact of adopting Topic 606, with the impact primarily related to our loyalty point program deferrals. The impact to revenues as a result of applying Topic 606 for the three- and nine-months ended September 30, 2018 was an increase of $0.1 million and a decrease of $1.2 million, respectively. Revenue Recognition Net sales include products and shipping and handling charges, net of estimates for product returns and any related sales incentives. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products. All revenue is recognized when we satisfy our performance obligations under the contract. The Company recognizes revenue by transferring the promised products to the customer, with revenue recognized at shipping point, the point in time the customer obtains control of the products. The Company recognizes revenue for shipping and handling charges at the time the products are delivered to or picked up by the customer. The Company estimates product returns based on historical return rates. The majority of the Company’s contracts have a single performance obligation and are short term in nature. Sales taxes and value added taxes in foreign jurisdictions that are collected from customers and remitted to governmental authorities are accounted for on a net basis and therefore are excluded from net sales. Contract Liabilities – Customer Loyalty Programs Contract liabilities, recorded as deferred revenue within the accrued expenses line in the Condensed Consolidated Balance Sheets, include loyalty point program deferrals with certain customers which are accounted for as a reduction in the transaction price and are generally recognized as points are redeemed for additional products on an annual basis. The Company recorded customer loyalty points under the cost provision method prior to the adoption of Topic 606. The loyalty point liability under the cost provision methodology was $1.9 million as of December 31, 2017. The Company recorded an additional liability of $11.2 million due to the cumulative impact of adopting Topic 606. Disaggregation of Revenue Please refer to Note 6 - Segment Information for revenue by segment and product line. Arrangements with Multiple Performance Obligations The Company’s contracts with customers may include multiple performance obligations. For such arrangements, the Company allocates revenues to each performance obligation based on its relative standalone selling price. The Company generally determines standalone selling prices based on the prices charged to customers for individual products sales to customers. Practical Expedients and Exemptions The Company generally expenses sales commissions when incurred because the amortization period would have been one year or less. These costs are recorded within selling expenses. The Company does not disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less.

THE COMPANY (Policies)

THE COMPANY (Policies)	9 Months Ended
THE COMPANY (Policies)	Sep. 30, 2018
THE COMPANY [Abstract]
Basis of Accounting	The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. The unaudited consolidated financial statements include the accounts of the Company and its Subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company’s financial information as of September 30, 2018, and for the three- and nine-month periods ended September 30, 2018 and 2017. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the fiscal year. The consolidated balance sheet as of December 31, 2017 has been prepared using information from the audited financial statements at that date. For further information, refer to the consolidated financial statements and accompanying footnotes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017.

ACCOUNTING PRONOUNCEMENTS (Poli

ACCOUNTING PRONOUNCEMENTS (Policies)	9 Months Ended
ACCOUNTING PRONOUNCEMENTS (Policies)	Sep. 30, 2018
ACCOUNTING PRONOUNCEMENTS [Abstract]
Accounting Pronouncements	In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606) In February 2016, the FASB issued ASU 2016-02, Leases (Subtopic 842) , but we do not expect a material impact on the Consolidated Statements of Income or Consolidated Statements of Cash Flows. In March 2016, the FASB issued ASU 2016-09, Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting In the second half of 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments Statement of Cash Flows (Topic 230): Restricted Cash. In January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a In January 2017, the FASB issued ASU 2017-04, Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment . This guidance simplifies the required test of goodwill for impairment by eliminating Step 2 from the goodwill impairment test. If a company determines in Step 1 of the goodwill impairment test that the carrying value of a reporting unit is less than the fair value, an impairment in that amount should be recorded to the income statement, rather than proceeding to Step 2. This ASU is effective for interim and annual impairment tests in fiscal years beginning after December 15, 2019. Early adoption is permitted. The adoption of this guidance is not expected to have a material impact on the Company’s consolidated financial statements. In December 2017, the FASB issued ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities The In February 2018, the FASB issued ASU 2018-02, Income Statement – Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. modifies, removes, and adds certain disclosure requirements on fair value measurements.

REVENUE RECOGNITION (Policies)

REVENUE RECOGNITION (Policies)	9 Months Ended
REVENUE RECOGNITION (Policies)	Sep. 30, 2018
REVENUE RECOGNITION [Abstract]
Revenue Recognition	Net sales include products and shipping and handling charges, net of estimates for product returns and any related sales incentives. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products. All revenue is recognized when we satisfy our performance obligations under the contract. The Company recognizes revenue by transferring the promised products to the customer, with revenue recognized at shipping point, the point in time the customer obtains control of the products. The Company recognizes revenue for shipping and handling charges at the time the products are delivered to or picked up by the customer. The Company estimates product returns based on historical return rates. The majority of the Company’s contracts have a single performance obligation and are short term in nature. Sales taxes and value added taxes in foreign jurisdictions that are collected from customers and remitted to governmental authorities are accounted for on a net basis and therefore are excluded from net sales.

DERIVATIVE FINANCIAL INSTRUME_2

DERIVATIVE FINANCIAL INSTRUMENTS (Tables)	9 Months Ended
DERIVATIVE FINANCIAL INSTRUMENTS (Tables)	Sep. 30, 2018
DERIVATIVE FINANCIAL INSTRUMENTS [Abstract]
Gains (Losses) Related to Derivative Instruments Not Designated as Hedging Instruments	The following table summarizes gains (losses) related to derivative instruments not designated as hedging instruments during the three- and nine-month periods ended September 30, 2018 and 2017 (U.S. dollars in thousands): Derivatives not designated as hedging instruments: Location of Gain (Loss) Recognized in Income Amount of Gain (Loss) Recognized in Income Three Months Ended September 30, Nine Months Ended September 30, 2018 2017 2018 2017 Foreign currency contracts Other income (expense) $ — $ — $ — $ (485 )
Gains (Losses) Related to Derivative Instruments Designated as Cash Flow Hedges	The following table summarizes gains (losses) related to derivative instruments recorded in other comprehensive income (loss) during the three- and nine-month periods ended September 30, 2018 and 2017 (U.S. dollars in thousands): Derivatives designated as hedging instruments: Amount of Gain (Loss) Recognized in Other Comprehensive Loss Three Months Ended September 30, Nine Months Ended September 30, 2018 2017 2018 2017 Foreign currency forward contracts $ — $ (27 ) $ (160 ) $ (207 ) The following table summarizes gains (losses) relating to derivative instruments reclassified from accumulated other comprehensive loss into income during the three- and nine-month periods ended September 30, 2018 and 2017 (U.S. dollars in thousands): Derivatives designated as hedging instruments: Location of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income Three Months Ended September 30, Nine Months Ended September 30, 2018 2017 2018 2017 Foreign currency forward contracts related to intercompany license fees and product sales hedges Revenue $ — $ (67 ) $ 18 $ 42 Foreign currency forward contracts related to intercompany selling expense hedges Selling expenses $ — $ 5 $ — $ 233

SEGMENT INFORMATION (Tables)

SEGMENT INFORMATION (Tables)	9 Months Ended
SEGMENT INFORMATION (Tables)	Sep. 30, 2018
SEGMENT INFORMATION [Abstract]
Revenue by Segment	Revenue by Segment Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2018 2017 2018 2017 Mainland China $ 226,645 $ 172,556 $ 669,432 $ 494,658 Americas/Pacific 93,580 85,672 289,859 240,094 South Korea 89,963 89,238 270,517 258,626 Southeast Asia 86,307 71,141 236,390 194,711 Japan 63,649 62,513 190,986 188,465 Hong Kong/Taiwan 44,949 41,050 138,147 120,069 EMEA 42,819 40,133 131,810 112,385 Other 27,400 1,395 68,580 3,890 Total $ 675,312 $ 563,698 $ 1,995,721 $ 1,612,898
Segment Contribution	Segment Contribution Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2018 2017 2018 2017 Mainland China $ 71,185 $ 42,375 $ 189,901 $ 130,085 Americas/Pacific 11,848 14,106 38,088 37,884 South Korea 24,754 23,713 75,836 70,503 Southeast Asia 21,204 17,380 58,245 43,763 Japan 15,162 12,786 41,777 36,134 Hong Kong/Taiwan 8,100 8,096 23,781 20,945 EMEA 2,614 2,896 10,438 8,304 Total segment contribution 154,867 121,352 438,066 347,618 Corporate and other (74,192 ) (56,990 ) (215,637 ) (172,255 ) Operating income 80,675 64,362 222,429 175,363 Other income (expense) (6,982 ) (1,172 ) (16,940 ) (8,470 ) Income before provision for income taxes $ 73,693 $ 63,190 $ 205,489 $ 166,893
Depreciation and Amortization and Capital Expenditures	Depreciation and Amortization Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2018 2017 2018 2017 Mainland China $ 3,132 $ 3,550 $ 10,063 $ 11,202 Americas/Pacific 229 375 722 1,425 South Korea 1,421 1,586 4,664 4,872 Southeast Asia 525 551 1,648 1,628 Japan 873 898 2,688 2,677 Hong Kong/Taiwan 279 353 923 999 EMEA 238 226 589 820 Other 15,994 9,906 41,536 28,902 Total $ 22,691 $ 17,455 $ 62,833 $ 52,525 Capital Expenditures Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2018 2017 2018 2017 Mainland China $ 2,117 $ 688 $ 5,015 $ 2,351 Americas/Pacific 223 136 652 697 South Korea 135 — 179 464 Southeast Asia 357 281 552 814 Japan 125 109 508 206 Hong Kong/Taiwan 31 2 629 1,119 EMEA 348 571 425 882 Other 10,528 9,427 34,333 32,432 Total $ 13,864 $ 11,214 $ 42,293 $ 38,965
Revenue by Product Line	Revenue by Product Line Three Months Ended September 30, Nine Months Ended September 30, 2018 2017 2018 2017 Nu Skin $ 384,635 $ 338,305 $ 1,237,547 $ 985,465 Pharmanex 261,892 224,031 687,789 623,046 Other 28,785 1,362 70,385 4,387 Totals $ 675,312 $ 563,698 $ 1,995,721 $ 1,612,898
Long-lived Assets by Major Markets	Long-Lived Assets by Major Market A major market is defined as a market with long-lived assets greater than 10% of consolidated long-lived assets and also includes the Company’s country of domicile (the U.S.). Long-lived assets in Mainland China consist primarily of property, plant and equipment related to manufacturing, distribution facilities and the Mainland China headquarters. Long-lived assets in the U.S. consist primarily of property, plant and equipment, including the Company’s corporate offices and distribution facilities. Long-lived assets by major markets are set forth below for the periods ended September 30, 2018 and December 31, 2017 (U.S. dollars in thousands): September 30, 2018 December 31, 2017 United States $ 357,426 $ 302,884 Mainland China 84,680 97,046 South Korea 36,609 42,211 Japan 7,195 9,342 All others 10,794 13,104 Total $ 496,704 $ 464,587

GOODWILL (Tables)

GOODWILL (Tables)	9 Months Ended
GOODWILL (Tables)	Sep. 30, 2018
GOODWILL [Abstract]
Goodwill	The following table presents goodwill allocated to the Company’s reportable segments for the periods ended September 30, 2018 and December 31, 2017 (U.S. dollars in thousands): September 30, 2018 December 31, 2017 Mainland China $ 32,179 $ 32,179 Americas/Pacific 9,449 9,449 South Korea 29,261 29,261 Southeast Asia 18,537 18,537 Japan 16,019 16,019 Hong Kong/Taiwan 6,634 6,634 EMEA 2,875 2,875 Other 72,469 — Total $ 187,423 $ 114,954

INVENTORY (Tables)

INVENTORY (Tables)	9 Months Ended
INVENTORY (Tables)	Sep. 30, 2018
INVENTORY [Abstract]
Inventories	Inventories consist of the following (U.S. dollars in thousands): September 30, 2018 December 31, 2017 Raw materials $ 89,830 $ 87,683 Finished goods 199,461 165,771 $ 289,291 $ 253,454

DEBT (Tables)

DEBT (Tables)	9 Months Ended
DEBT (Tables)	Sep. 30, 2018
DEBT [Abstract]
Debt Facilities	The following table summarizes the Company’s debt facilities as of September 30, 2018 and December 31, 2017: Facility or Arrangement Original Principal Amount Balance as of September 30, 2018 (1)(2) Balance as of December 31, 2017 (2) Interest Rate Repayment terms October 2014 Credit Agreement term loan facility: U.S. dollar denominated: $127.5 million — $94.8 million Variable 30 day: 4.627% Principal amount was paid in full during April 2018. Japanese yen denominated: 6.6 billion yen — 4.9 billion yen ($43.5 million as of December 31, 2017) Variable 30 day: 2.7595% Principal amount was paid in full during April 2018. October 2014 Credit Agreement revolving credit facility: — $47.5 million Variable 30 day: 4.594% Principal amount was paid in full during April 2018 and credit line was closed. April 2018 Credit Agreement term loan facility: U.S. dollar denominated: $400.0 million $390.0 million — Variable 30 day: 4.49% 35% of the principal amount is payable in increasing quarterly installments over a five-year period that began on June 30, 2018, with the remainder payable at the end of the five-year term. April 2018 Credit Agreement revolving credit facility: $62.5 million — Variable 30 day: 4.49% Revolving line of credit expires April 18, 2023. Japan subsidiary loan: 2.1 billion yen — 0.7 billion yen ($5.9 million as of December 31, 2017) 0.66% Principal amount was paid in full during July 2018. Convertible note: $210.0 million — $210.0 million 4.75% Principal amount was paid in full during April 2018. (1) As of September 30, 2018, the current portion of the Company’s debt (i.e. becoming due in the next 12 months) included $20.0 million of the balance of its U.S. dollar denominated debt under the New Credit Agreement facility. The Company has classified the $62.5 million borrowed under the revolving line of credit as short-term debt because it is the Company’s intention to use the line of credit to borrow and pay back funds over short periods of time. (2) The carrying value of the debt reflects the amounts stated in the above table less debt issuance costs of $4.2 million as of September 30, 2018 related to the credit agreement; and a debt discount of $9.1 million and debt issuance costs of $4.0 million (consisting of $11.1 million related to the Convertible Note and $2.0 million related to the credit agreement) as of December 31, 2017, which is not reflected in this table.

FAIR VALUE (Tables)

FAIR VALUE (Tables)	9 Months Ended
FAIR VALUE (Tables)	Sep. 30, 2018
FAIR VALUE [Abstract]
Assets and Liabilities Measured at Fair Value on a Recurring Basis	The following tables present the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis (U.S. dollars in thousands): Fair Value at September 30, 2018 Level 1 Level 2 Level 3 Total Financial assets (liabilities): Cash equivalents and current investments $ 38,282 $ — $ — $ 38,282 Other long-term assets 3,582 — — 3,582 Forward contracts — — — — Life insurance contracts — — 39,248 39,248 Total $ 41,864 $ — $ 39,248 $ 81,112 Fair Value at December 31, 2017 Level 1 Level 2 Level 3 Total Financial assets (liabilities): Cash equivalents and current investments $ 36,531 $ — $ — $ 36,531 Other long-term assets 3,726 — — 3,726 Forward contracts — 158 — 158 Life insurance contracts — — 37,737 37,737 Total $ 40,257 $ 158 $ 37,737 $ 78,152
Changes in Fair Value of Level 3 Marketable Securities	The following table provides a summary of changes in fair value of the Company’s Level 3 marketable securities (U.S. dollars in thousands): Life Insurance Contracts Beginning balance at January 1, 2018 $ 37,737 Actual return on plan assets 1,746 Purchases and issuances — Sales and settlements (235 ) Transfers into Level 3 — Ending balance at September 30, 2018 $ 39,248

ACQUISITIONS (Tables)

ACQUISITIONS (Tables)	9 Months Ended
ACQUISITIONS (Tables)	Sep. 30, 2018
ACQUISITIONS [Abstract]
Acquisitions	The following table summarizes the fair value of consideration transferred for the acquisitions disclosed above (in thousands): Innuvate Treviso L&W Holdings Total Total cash consideration $ 17,587 $ 14,648 $ — $ 32,235 Shares issued in conjunction with acquisition 5,863 69,252 25,000 100,115 Total consideration $ 23,450 $ 83,900 $ 25,000 132,350 Previously held equity interest in equity method Investments (1) 8,748 30,281 — 39,029 Total $ 32,198 $ 114,181 $ 25,000 $ 171,379 (1) The acquisitions of Innuvate and Treviso are considered step acquisitions, and accordingly, the Company remeasured its pre-existing 27% equity interest in Innuvate and 35% of Treviso immediately prior to completion of the acquisition to its estimated fair value of approximately $39.0 million. As a result of the remeasurement, the Company recorded a gain of approximately $13.6 million within other income (expense), during the first quarter of 2018, representing the excess of the approximate $39.0 million estimated fair value of its pre-existing 27% equity interest in Innuvate and 35% equity interest of Treviso over its transaction date carrying value of approximately $25.4 million. The following table summarizes the fair value of the assets acquired for the acquisitions disclosed above (in thousands): Innuvate Treviso L&W Holdings Life Amount Life Amount Life Amount Total current assets $ 6,219 $ 19,659 $ 7,353 Fixed assets 9,291 33,282 114 Customer list 9 years 5,100 9 years 16,500 7 years 6,500 Order backlog 5 months 200 10 months 4,700 4 months 900 Trademarks 7 years 900 6 years 1,300 5 years 600 Total current liabilities (3,942 ) (3,740 ) (1,495 ) Other non-current liabilities — — (1,731 ) Total identifiable net assets acquired 17,768 71,701 12,241 Goodwill 17,230 42,480 12,759 Fair value of noncontrolling interest (2,800 ) — — Total consideration and value to be allocated to net assets $ 32,198 $ 114,181 $ 25,000

THE COMPANY (Details)

THE COMPANY (Details)	9 Months Ended
THE COMPANY (Details)	Sep. 30, 2018Segment
THE COMPANY [Abstract]
Number of segments	7

NET INCOME PER SHARE (Details)

NET INCOME PER SHARE (Details) - shares shares in Millions	3 Months Ended		9 Months Ended
NET INCOME PER SHARE (Details) - shares shares in Millions	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Stock Options [Member]
Net Income per Share [Abstract]
Anti-dilutive shares excluded from calculation of diluted earnings per share (in shares)	0.5	0.2	0.9	0.4

DIVIDENDS PER SHARE (Details)

DIVIDENDS PER SHARE (Details) - USD ($) $ / shares in Units, $ in Thousands	Sep. 12, 2018	Jun. 13, 2018	Mar. 14, 2018	Oct. 31, 2018	Jul. 31, 2018	Apr. 30, 2018	Feb. 28, 2018	Sep. 30, 2018	Sep. 30, 2017
Dividends per Share [Abstract]
Payment of cash dividends								$ 60,395	$ 57,065
Dividend Declared 2018-Q1 [Member]
Dividends per Share [Abstract]
Dividend payable, date declared								2018-02
Dividend payable per share (in dollars per share)							$ 0.365
Payment of cash dividends			$ 19,800
Dividend payable, date to be paid								Mar. 14, 2018
Dividend payable, date of record								Feb. 26, 2018
Dividend Declared 2018-Q2 [Member]
Dividends per Share [Abstract]
Dividend payable, date declared								2018-04
Dividend payable per share (in dollars per share)						$ 0.365
Payment of cash dividends		$ 20,300
Dividend payable, date to be paid								Jun. 13, 2018
Dividend payable, date of record								May 25, 2018
Dividend Declared 2018-Q3 [Member]
Dividends per Share [Abstract]
Dividend payable, date declared								2018-07
Dividend payable per share (in dollars per share)					$ 0.365
Payment of cash dividends	$ 20,300
Dividend payable, date to be paid								Sep. 12, 2018
Dividend payable, date of record								Aug. 31, 2018
Dividend Declared 2018-Q4 [Member] \| Subsequent Event [Member]
Dividends per Share [Abstract]
Dividend payable, date declared				2018-10
Dividend payable per share (in dollars per share)				$ 0.365
Dividend payable, date to be paid				Dec. 12, 2018
Dividend payable, date of record				Nov. 30, 2018

DERIVATIVE FINANCIAL INSTRUME_3

DERIVATIVE FINANCIAL INSTRUMENTS (Details) $ in Thousands, ¥ in Billions	3 Months Ended		9 Months Ended
	Sep. 30, 2018USD ($)	Sep. 30, 2017USD ($)	Sep. 30, 2018USD ($)	Sep. 30, 2017USD ($)	Dec. 31, 2017USD ($)	Sep. 30, 2017JPY (¥)
Foreign Currency Derivatives [Abstract]
Unrealized gains/(losses) related to foreign currency cash flow hedges included in accumulated other comprehensive loss	$ 0		$ 0		$ 100
Cumulative translation adjustments included in accumulated other comprehensive loss	82,600		82,600		$ 66,400
Foreign Currency Forward Contracts [Member] \| Designated as Hedging Instrument [Member] \| Cash Flow Hedges [Member]
Foreign Currency Derivatives [Abstract]
Fair value	0	$ 300	0	$ 300
Foreign Currency Forward Contracts [Member] \| Designated as Hedging Instrument [Member] \| Cash Flow Hedges [Member] \| Japanese Yen [Member]
Foreign Currency Derivatives [Abstract]
Notional amount		12,400		12,400		¥ 1.4
Foreign Currency Forward Contracts [Member] \| Other Comprehensive Loss [Member] \| Designated as Hedging Instrument [Member] \| Cash Flow Hedges [Member]
Foreign Currency Derivatives [Abstract]
Gain (loss) recognized in other comprehensive income loss	0	(27)	(160)	(207)
Foreign Currency Forward Contracts [Member] \| Other Income (Expense) [Member] \| Not Designated as Hedging Instrument [Member] \| Fair Value Hedges [Member]
Foreign Currency Derivatives [Abstract]
Gain (loss) recognized in income	0	0	0	(485)
Foreign Currency Forward Contracts [Member] \| Revenue [Member] \| Designated as Hedging Instrument [Member] \| Cash Flow Hedges [Member]
Foreign Currency Derivatives [Abstract]
Gain (loss) reclassified from accumulated other comprehensive loss into income	0	(67)	18	42
Foreign Currency Forward Contracts [Member] \| Selling Expenses [Member] \| Designated as Hedging Instrument [Member] \| Cash Flow Hedges [Member]
Foreign Currency Derivatives [Abstract]
Gain (loss) reclassified from accumulated other comprehensive loss into income	$ 0	$ 5	$ 0	$ 233

REPURCHASES OF COMMON STOCK (De

REPURCHASES OF COMMON STOCK (Details) - Common Class A [Member] - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Jul. 31, 2018
Repurchases of Common Stock [Abstract]
Common stock repurchased (in shares)	0.2	0.4	0.6	0.8
Common stock repurchased	$ 12.4	$ 25.7	$ 48.2	$ 47.8
Authorized amount for repurchase program					$ 500
Available for repurchase under the repurchase program	$ 492.4		$ 492.4

SEGMENT INFORMATION, Revenue by

SEGMENT INFORMATION, Revenue by Segment (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018USD ($)	Sep. 30, 2017USD ($)	Sep. 30, 2018USD ($)SegmentMarket	Sep. 30, 2017USD ($)
SEGMENT INFORMATION [Abstract]
Number of markets \| Market			50
Number of segments \| Segment			7
Revenue by Segment [Abstract]
Revenue	$ 675,312	$ 563,698	$ 1,995,721	$ 1,612,898
Operating Segment [Member]
Revenue by Segment [Abstract]
Revenue	675,312	563,698	1,995,721	1,612,898
Operating Segment [Member] \| Mainland China [Member]
Revenue by Segment [Abstract]
Revenue	226,645	172,556	669,432	494,658
Operating Segment [Member] \| Americas/Pacific [Member]
Revenue by Segment [Abstract]
Revenue	93,580	85,672	289,859	240,094
Operating Segment [Member] \| South Korea [Member]
Revenue by Segment [Abstract]
Revenue	89,963	89,238	270,517	258,626
Operating Segment [Member] \| Southeast Asia [Member]
Revenue by Segment [Abstract]
Revenue	86,307	71,141	236,390	194,711
Operating Segment [Member] \| Japan [Member]
Revenue by Segment [Abstract]
Revenue	63,649	62,513	190,986	188,465
Operating Segment [Member] \| Hong Kong/Taiwan [Member]
Revenue by Segment [Abstract]
Revenue	44,949	41,050	138,147	120,069
Operating Segment [Member] \| EMEA [Member]
Revenue by Segment [Abstract]
Revenue	42,819	40,133	131,810	112,385
Operating Segment [Member] \| Other [Member]
Revenue by Segment [Abstract]
Revenue	$ 27,400	$ 1,395	$ 68,580	$ 3,890

SEGMENT INFORMATION, Segment Co

SEGMENT INFORMATION, Segment Contribution (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Segment Contribution [Abstract]
Operating income	$ 80,675	$ 64,362	$ 222,429	$ 175,363
Other income (expense)	(6,982)	(1,172)	(16,940)	(8,470)
Income before provision for income taxes	73,693	63,190	205,489	166,893
Operating Segment [Member]
Segment Contribution [Abstract]
Operating income	154,867	121,352	438,066	347,618
Operating Segment [Member] \| Mainland China [Member]
Segment Contribution [Abstract]
Operating income	71,185	42,375	189,901	130,085
Operating Segment [Member] \| Americas/Pacific [Member]
Segment Contribution [Abstract]
Operating income	11,848	14,106	38,088	37,884
Operating Segment [Member] \| South Korea [Member]
Segment Contribution [Abstract]
Operating income	24,754	23,713	75,836	70,503
Operating Segment [Member] \| Southeast Asia [Member]
Segment Contribution [Abstract]
Operating income	21,204	17,380	58,245	43,763
Operating Segment [Member] \| Japan [Member]
Segment Contribution [Abstract]
Operating income	15,162	12,786	41,777	36,134
Operating Segment [Member] \| Hong Kong/Taiwan [Member]
Segment Contribution [Abstract]
Operating income	8,100	8,096	23,781	20,945
Operating Segment [Member] \| EMEA [Member]
Segment Contribution [Abstract]
Operating income	2,614	2,896	10,438	8,304
Corporate and Other [Member]
Segment Contribution [Abstract]
Operating income	$ (74,192)	$ (56,990)	$ (215,637)	$ (172,255)

SEGMENT INFORMATION, Depreciati

SEGMENT INFORMATION, Depreciation and Amortization and Capital Expenditures (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Summarized Financial Information [Abstract]
Depreciation and amortization	$ 22,691	$ 17,455	$ 62,833	$ 52,525
Capital expenditures	13,864	11,214	42,293	38,965
Other [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	15,994	9,906	41,536	28,902
Capital expenditures	10,528	9,427	34,333	32,432
Reportable Geographic Region [Member] \| Mainland China [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	3,132	3,550	10,063	11,202
Capital expenditures	2,117	688	5,015	2,351
Reportable Geographic Region [Member] \| Americas/Pacific [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	229	375	722	1,425
Capital expenditures	223	136	652	697
Reportable Geographic Region [Member] \| South Korea [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	1,421	1,586	4,664	4,872
Capital expenditures	135	0	179	464
Reportable Geographic Region [Member] \| Southeast Asia [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	525	551	1,648	1,628
Capital expenditures	357	281	552	814
Reportable Geographic Region [Member] \| Japan [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	873	898	2,688	2,677
Capital expenditures	125	109	508	206
Reportable Geographic Region [Member] \| Hong Kong/Taiwan [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	279	353	923	999
Capital expenditures	31	2	629	1,119
Reportable Geographic Region [Member] \| EMEA [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	238	226	589	820
Capital expenditures	$ 348	$ 571	$ 425	$ 882

SEGMENT INFORMATION, Revenue _2

SEGMENT INFORMATION, Revenue by Major Market (Details)	9 Months Ended
SEGMENT INFORMATION, Revenue by Major Market (Details)	Sep. 30, 2018Market
SEGMENT INFORMATION [Abstract]
Number of major markets	3
Number of markets	50

SEGMENT INFORMATION, Revenue _3

SEGMENT INFORMATION, Revenue by Product Line (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Revenue by Product Line [Abstract]
Revenue	$ 675,312	$ 563,698	$ 1,995,721	$ 1,612,898
Nu Skin [Member]
Revenue by Product Line [Abstract]
Revenue	384,635	338,305	1,237,547	985,465
Pharmanex [Member]
Revenue by Product Line [Abstract]
Revenue	261,892	224,031	687,789	623,046
Other [Member]
Revenue by Product Line [Abstract]
Revenue	$ 28,785	$ 1,362	$ 70,385	$ 4,387

SEGMENT INFORMATION, Long-Lived

SEGMENT INFORMATION, Long-Lived Assets by Major Market (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Long-Lived Assets by Major Market [Abstract]
Long-lived assets	$ 496,704	$ 464,587
Major Markets [Member] \| United States [Member]
Long-Lived Assets by Major Market [Abstract]
Long-lived assets	357,426	302,884
Major Markets [Member] \| Mainland China [Member]
Long-Lived Assets by Major Market [Abstract]
Long-lived assets	84,680	97,046
Major Markets [Member] \| South Korea [Member]
Long-Lived Assets by Major Market [Abstract]
Long-lived assets	36,609	42,211
Major Markets [Member] \| Japan [Member]
Long-Lived Assets by Major Market [Abstract]
Long-lived assets	7,195	9,342
Major Markets [Member] \| All Others [Member]
Long-Lived Assets by Major Market [Abstract]
Long-lived assets	$ 10,794	$ 13,104

GOODWILL (Details)

GOODWILL (Details) $ in Thousands	9 Months Ended
GOODWILL (Details) $ in Thousands	Sep. 30, 2018USD ($)Segment	Dec. 31, 2017USD ($)
Goodwill [Abstract]
Number of segments \| Segment	7
Goodwill	$ 187,423	$ 114,954
Mainland China [Member]
Goodwill [Abstract]
Goodwill	32,179	32,179
Americas/Pacific [Member]
Goodwill [Abstract]
Goodwill	9,449	9,449
South Korea [Member]
Goodwill [Abstract]
Goodwill	29,261	29,261
Southeast Asia [Member]
Goodwill [Abstract]
Goodwill	18,537	18,537
Japan [Member]
Goodwill [Abstract]
Goodwill	16,019	16,019
Hong Kong/Taiwan [Member]
Goodwill [Abstract]
Goodwill	6,634	6,634
EMEA [Member]
Goodwill [Abstract]
Goodwill	2,875	2,875
Other [Member]
Goodwill [Abstract]
Goodwill	$ 72,469	$ 0

INVENTORY (Details)

INVENTORY (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Inventories [Abstract]
Raw materials	$ 89,830	$ 87,683
Finished goods	199,461	165,771
Inventories	289,291	$ 253,454
Companies Acquired in Q1-2018 [Member]
Inventories [Abstract]
Inventories	$ 23,300

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
INCOME TAXES (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Mar. 31, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Jun. 30, 2018	Dec. 31, 2017
Income Taxes [Abstract]
Provision for income taxes	$ 20,547		$ 21,518	$ 65,843	$ 55,691
Effective tax rate	27.90%		34.10%	32.00%	33.40%
Net deferred tax assets	$ 5,400			$ 5,400
Net deferred tax liabilities							$ 2,900
Minimum [Member]
Income Taxes [Abstract]
Decrease in unrecognized tax benefits within the next 12 months that is reasonably possible	100			$ 100
Maximum [Member]
Income Taxes [Abstract]
Statute of limitations related to income tax examinations				10 years
Income Taxes [Abstract]
Decrease in unrecognized tax benefits within the next 12 months that is reasonably possible	$ 1,000			$ 1,000
Mainland China [Member]
Income Taxes [Abstract]
Foreign earnings permanently reinvested						$ 60,000
Indonesia [Member]
Income Taxes [Abstract]
Tax assessment		$ 5,800

DEBT, Existing Credit Agreement

DEBT, Existing Credit Agreement (Details) $ in Millions, ¥ in Billions	9 Months Ended
	Sep. 30, 2018USD ($)	Sep. 30, 2018JPY (¥)	Dec. 31, 2017USD ($)	[1]	Dec. 31, 2017JPY (¥)	[1]	Oct. 09, 2014USD ($)	Oct. 09, 2014JPY (¥)
Existing Credit Agreement [Member] \| Maximum [Member]
Debt [Abstract]
Consolidated leverage ratio	2.25
Existing Credit Agreement [Member] \| Minimum [Member]
Debt [Abstract]
Consolidated interest coverage ratio	3
Term Loan Facility [Member]
Debt [Abstract]
Original principal amount	$ 127.5						$ 127.5
Term of facility	5 years
Outstanding balance	$ 0		$ 94.8
Japanese Yen Term Loan Facility [Member]
Debt [Abstract]
Original principal amount \| ¥		¥ 6.6						¥ 6.6
Term of facility	5 years
Outstanding balance	$ 0	¥ 0	43.5		¥ 4.9
Revolving Credit Facility [Member]
Debt [Abstract]
Borrowing capacity							$ 187.5
Term of facility	5 years
Outstanding balance	$ 0		$ 47.5

[1]	The carrying value of the debt reflects the amounts stated in the above table less debt issuance costs of $4.2 million as of September 30, 2018 related to the credit agreement; and a debt discount of $9.1 million and debt issuance costs of $4.0 million (consisting of $11.1 million related to the Convertible Note and $2.0 million related to the credit agreement) as of December 31, 2017, which is not reflected in this table.

DEBT, New Credit Agreement (Det

DEBT, New Credit Agreement (Details) $ in Thousands	Apr. 18, 2018USD ($)	Sep. 30, 2018USD ($)	Sep. 30, 2017USD ($)
Long-term Debt, Current and Noncurrent [Abstract]
Proceeds from debt		$ 582,398	$ 67,000
New Credit Agreement [Member] \| Maximum [Member]
Long-term Debt, Current and Noncurrent [Abstract]
Consolidated leverage ratio		2.25
New Credit Agreement [Member] \| Minimum [Member]
Long-term Debt, Current and Noncurrent [Abstract]
Consolidated interest coverage ratio		3
Term Loan Facility [Member]
Long-term Debt, Current and Noncurrent [Abstract]
Original principal amount	$ 400,000	$ 400,000
Term of loan		5 years
Frequency of payment		Quarterly
Term Loan Facility [Member] \| First Year [Member]
Long-term Debt, Current and Noncurrent [Abstract]
Annual amortization percentage	5.00%
Term Loan Facility [Member] \| Second Year [Member]
Long-term Debt, Current and Noncurrent [Abstract]
Annual amortization percentage	5.00%
Term Loan Facility [Member] \| Third Year [Member]
Long-term Debt, Current and Noncurrent [Abstract]
Annual amortization percentage	7.50%
Term Loan Facility [Member] \| Fourth Year [Member]
Long-term Debt, Current and Noncurrent [Abstract]
Annual amortization percentage	7.50%
Term Loan Facility [Member] \| Fifth Year [Member]
Long-term Debt, Current and Noncurrent [Abstract]
Annual amortization percentage	10.00%
Term Loan Facility [Member] \| LIBOR [Member]
Long-term Debt, Current and Noncurrent [Abstract]
Basis spread on variable rate	2.25%
Revolving Credit Facility [Member]
Long-term Debt, Current and Noncurrent [Abstract]
Borrowing capacity	$ 350,000
Term of loan		5 years
Proceeds from debt	$ 78,500
Revolving Credit Facility [Member] \| LIBOR [Member]
Long-term Debt, Current and Noncurrent [Abstract]
Basis spread on variable rate	2.25%

Debt, Convertible Note (Details

Debt, Convertible Note (Details)	Apr. 18, 2018USD ($)	Feb. 28, 2018shares	Jun. 16, 2016USD ($)	Sep. 30, 2018USD ($)$ / shares	Mar. 31, 2018USD ($)	Apr. 17, 2018USD ($)	Sep. 30, 2018USD ($)d$ / sharesshares	Sep. 30, 2017USD ($)
Convertible Debt [Abstract]
Debt issuance costs							$ 7,243,000	$ 0
Loss on extinguishment of debt							(7,220,000)	$ 0
Class A Common Stock [Member]
Convertible Debt [Abstract]
Shares issued (in shares) \| shares		1,535,652
Convertible Note [Member]
Convertible Debt [Abstract]
Original principal amount			$ 210,000,000	$ 210,000,000			$ 210,000,000
Interest rate				4.75%			4.75%
Redemption price, percentage of principal amount redeemed							100.00%
Threshold percentage of stock price trigger							180.00%
Threshold trading days \| d							20
Threshold final trading days \| d							3
Threshold consecutive trading days \| d							30
Principal amount increments that can be repurchased upon a change in control or termination of trading of common stock							$ 1,000
Principal amount increments that can be converted							$ 1,000
Holding period following issue date before notes can be converted							6 months
Initial conversion rate (in shares) \| shares							21.5054
Initial conversion price (in dollars per share) \| $ / shares				$ 46.50			$ 46.50
Proceeds from issuance of notes			210,000,000
Liability component of convertible notes			199,100,000
Equity component of convertible notes allocated to additional paid-in capital			$ 10,900,000
Effective interest rate				7.10%			7.10%
Debt issuance costs							$ 6,600,000
Additions to deferred financing cost							6,300,000
Adjustments to additional paid-in capital for debt issuance costs							300,000
Interest expense				$ 0			3,500,000
Contractual interest				0			3,000,000
Amortization of debt issuance costs and debt discount				$ 0			$ 500,000
Payment for principal and accrued interest	$ 213,400,000
Accrued interest						$ 3,400,000
Loss on extinguishment of debt					$ (7,220,000)

Debt, Debt Facilities (Details)

Debt, Debt Facilities (Details) $ in Thousands, ¥ in Billions	9 Months Ended
	Sep. 30, 2018USD ($)		Sep. 30, 2018JPY (¥)	Apr. 18, 2018USD ($)	Dec. 31, 2017USD ($)		Dec. 31, 2017JPY (¥)		Jun. 16, 2016USD ($)	Oct. 09, 2014USD ($)	Oct. 09, 2014JPY (¥)
Debt [Abstract]
Current portion of debt	$ 82,455				$ 77,840
Unamortized debt issuance costs	4,200				4,000
Unamortized debt discount					9,100
October 2014 Credit Agreement Term Loan Facility [Member]
Debt [Abstract]
Original principal amount	127,500									$ 127,500
Balance	$ 0				94,800	[1]
Interest rate	Variable 30 day: 4.627%
Interest rate	4.627%		4.627%
Term of variable rate	30 days
Repayment terms	Principal amount was paid in full during April 2018.
Term of loan	5 years
Current portion of debt	$ 20,000
October 2014 Credit Agreement Japanese Yen Term Loan Facility [Member]
Debt [Abstract]
Original principal amount \| ¥			¥ 6.6								¥ 6.6
Balance	$ 0		¥ 0		43,500	[1]	¥ 4.9	[1]
Interest rate	Variable 30 day: 2.7595%
Interest rate	2.7595%		2.7595%
Term of variable rate	30 days
Repayment terms	Principal amount was paid in full during April 2018.
Term of loan	5 years
October 2014 Credit Agreement Revolving Credit Facility [Member]
Debt [Abstract]
Balance	$ 0				47,500	[1]
Interest rate	Variable 30 day: 4.594%
Interest rate	4.594%		4.594%
Term of variable rate	30 days
Repayment terms	Principal amount was paid in full during April 2018 and credit line was closed.
Term of loan	5 years
April 2018 Credit Agreement Term Loan Facility [Member]
Debt [Abstract]
Original principal amount	$ 400,000			$ 400,000
Balance	$ 390,000	[1],[2]			0
Interest rate	Variable 30 day: 4.49%
Interest rate	4.49%		4.49%
Term of variable rate	30 days
Repayment terms	35% of the principal amount is payable in increasing quarterly installments over a five-year period that began on June 30, 2018, with the remainder payable at the end of the five-year term.
Percentage of principal payable in installments	35.00%
Frequency of payment	Quarterly
Term of loan	5 years
April 2018 Credit Agreement Revolving Credit Facility [Member]
Debt [Abstract]
Balance	$ 62,500	[1],[2]			0
Interest rate	Variable 30 day: 4.49%
Interest rate	4.49%		4.49%
Term of variable rate	30 days
Repayment terms	Revolving line of credit expires April 18, 2023.
Term of loan	5 years
Japan Subsidiary Loan [Member]
Debt [Abstract]
Original principal amount \| ¥			¥ 2.1
Balance	$ 0		¥ 0		5,900		¥ 0.7
Interest rate	0.66%		0.66%
Repayment terms	Principal amount was paid in full during July 2018.
Convertible Note [Member]
Debt [Abstract]
Original principal amount	$ 210,000								$ 210,000
Balance	$ 0				210,000	[1]
Interest rate	7.10%		7.10%
Interest rate	4.75%		4.75%
Repayment terms	Principal amount was paid in full during April 2018.
Unamortized debt discount and debt issuance costs					11,100
Credit Agreement [Member]
Debt [Abstract]
Unamortized debt discount and debt issuance costs					$ 2,000

[1]	The carrying value of the debt reflects the amounts stated in the above table less debt issuance costs of $4.2 million as of September 30, 2018 related to the credit agreement; and a debt discount of $9.1 million and debt issuance costs of $4.0 million (consisting of $11.1 million related to the Convertible Note and $2.0 million related to the credit agreement) as of December 31, 2017, which is not reflected in this table.
[2]	As of September 30, 2018, the current portion of the Company's debt (i.e. becoming due in the next 12 months) included $20.0 million of the balance of its U.S. dollar denominated debt under the New Credit Agreement facility. The Company has classified the $62.5 million borrowed under the revolving line of credit as short-term debt because it is the Company's intention to use the line of credit to borrow and pay back funds over short periods of time.

FAIR VALUE (Details)

FAIR VALUE (Details) - USD ($) $ in Thousands	9 Months Ended
FAIR VALUE (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Fair Value on a Recurring Basis [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	$ 38,282	$ 36,531
Other long-term assets	3,582	3,726
Forward contracts	0	158
Life insurance contracts	39,248	37,737
Financial assets (liabilities), net	81,112	78,152
Fair Value on a Recurring Basis [Member] \| Level 1 [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	38,282	36,531
Other long-term assets	3,582	3,726
Forward contracts	0	0
Life insurance contracts	0	0
Financial assets (liabilities), net	41,864	40,257
Fair Value on a Recurring Basis [Member] \| Level 2 [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	0	0
Other long-term assets	0	0
Forward contracts	0	158
Life insurance contracts	0	0
Financial assets (liabilities), net	0	158
Fair Value on a Recurring Basis [Member] \| Level 3 [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	0	0
Other long-term assets	0	0
Forward contracts	0	0
Life insurance contracts	39,248	37,737
Financial assets (liabilities), net	39,248	$ 37,737
Life Insurance Contracts [Member]
Changes in Fair Value of Level 3 Marketable Securities [Roll Forward]
Beginning balance	37,737
Actual return on plan assets	1,746
Purchases and issuances	0
Sales and settlements	(235)
Transfers into Level 3	0
Ending balance	$ 39,248

ACCOUNTING PRONOUNCEMENTS (Deta

ACCOUNTING PRONOUNCEMENTS (Details) - USD ($) $ in Millions	Dec. 31, 2017	Dec. 31, 2016
ASC Topic 606 [Member]
Accounting Pronouncements [Abstract]
Cumulative impact on opening retained earnings	$ 11.2
ASU 2016-09 [Member] \| Retained Earnings [Member]
Accounting Pronouncements [Abstract]
Cumulative adjustment		$ (2.8)
ASU 2016-09 [Member] \| Additional Paid-in Capital [Member]
Accounting Pronouncements [Abstract]
Cumulative adjustment		$ 2.8

COST OF SALES (Details)

COST OF SALES (Details) $ in Millions	3 Months Ended
COST OF SALES (Details) $ in Millions	Mar. 31, 2016USD ($)
COST OF SALES [Abstract]
Customs expense	$ 31.4

ACQUISITIONS (Details)

ACQUISITIONS (Details) - USD ($) $ in Thousands		Feb. 12, 2018	Jan. 22, 2018	Sep. 30, 2018	Sep. 30, 2017	Feb. 11, 2018	Jan. 21, 2018	Dec. 31, 2017
Fair Value of Consideration Transferred for Acquisition [Abstract]
Total cash consideration				$ 32,235
Shares issued in conjunction with acquisition				100,115
Total consideration				132,350
Previously held equity interest in equity method	[1]			39,029
Total				171,379
Gain on step acquisition				13,644	$ 0
Carrying value of investments		$ 25,400
Fair Value of Assets Acquired [Abstract]
Goodwill				$ 187,423				$ 114,954
Nutritional Product Manufacturer [Member]
Acquisitions [Abstract]
Percentage of entity acquired			92.00%
Percentage of acquired entity held by third party			8.00%
Innuvate [Member]
Acquisitions [Abstract]
Percentage of entity acquired			73.00%
Ownership interest in equity method investment							27.00%
Fair Value of Consideration Transferred for Acquisition [Abstract]
Total cash consideration			$ 17,587
Shares issued in conjunction with acquisition			5,863
Total consideration			23,450
Previously held equity interest in equity method	[1]		8,748
Total			32,198
Fair Value of Assets Acquired [Abstract]
Total current assets			6,219
Fixed assets			9,291
Total current liabilities			(3,942)
Other non-current liabilities			0
Total identifiable net assets acquired			17,768
Goodwill			17,230
Fair value of noncontrolling interest			(2,800)
Total consideration and value to be allocated to net assets			32,198
Innuvate [Member] \| Customer List [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets			5,100
Useful life				9 years
Innuvate [Member] \| Order Backlog [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets			200
Useful life				5 months
Innuvate [Member] \| Trademarks [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets			$ 900
Useful life				7 years
Treviso [Member]
Acquisitions [Abstract]
Percentage of entity acquired		65.00%
Ownership interest in equity method investment						35.00%
Fair Value of Consideration Transferred for Acquisition [Abstract]
Total cash consideration		$ 14,648
Shares issued in conjunction with acquisition		69,252
Total consideration		83,900
Previously held equity interest in equity method	[1]	30,281
Total		114,181
Fair Value of Assets Acquired [Abstract]
Total current assets		19,659
Fixed assets		33,282
Total current liabilities		(3,740)
Other non-current liabilities		0
Total identifiable net assets acquired		71,701
Goodwill		42,480
Total consideration and value to be allocated to net assets		114,181
Treviso [Member] \| Customer List [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets		16,500
Useful life				9 years
Treviso [Member] \| Order Backlog [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets		4,700
Useful life				10 months
Treviso [Member] \| Trademarks [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets		$ 1,300
Useful life				6 years
L&W Holdings [Member]
Acquisitions [Abstract]
Percentage of entity acquired		100.00%
Fair Value of Consideration Transferred for Acquisition [Abstract]
Total cash consideration		$ 0
Shares issued in conjunction with acquisition		25,000
Total consideration		25,000
Previously held equity interest in equity method		0
Total		25,000
Fair Value of Assets Acquired [Abstract]
Total current assets		7,353
Fixed assets		114
Total current liabilities		(1,495)
Other non-current liabilities		(1,731)
Total identifiable net assets acquired		12,241
Goodwill		12,759
Total consideration and value to be allocated to net assets		25,000
L&W Holdings [Member] \| Customer List [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets		6,500
Useful life				7 years
L&W Holdings [Member] \| Order Backlog [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets		900
Useful life				4 months
L&W Holdings [Member] \| Trademarks [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets		$ 600
Useful life				5 years

[1]	The acquisitions of Innuvate and Treviso are considered step acquisitions, and accordingly, the Company remeasured its pre-existing 27% equity interest in Innuvate and 35% of Treviso immediately prior to completion of the acquisition to its estimated fair value of approximately $39.0 million. As a result of the remeasurement, the Company recorded a gain of approximately $13.6 million within other income (expense), during the first quarter of 2018, representing the excess of the approximate $39.0 million estimated fair value of its pre-existing 27% equity interest in Innuvate and 35% equity interest of Treviso over its transaction date carrying value of approximately $25.4 million.

REVENUE RECOGNITION, Adoption o

REVENUE RECOGNITION, Adoption of ASC Topic 606 (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Adoption of ASC Topic 606 [Abstract]
Revenues	$ (675,312)	$ (563,698)	$ (1,995,721)	$ (1,612,898)
ASC Topic 606 [Member]
Adoption of ASC Topic 606 [Abstract]
Cumulative impact on opening retained earnings					$ 11,200
Impact of Adopting ASC Topic 606 [Member] \| ASC Topic 606 [Member]
Adoption of ASC Topic 606 [Abstract]
Revenues	$ 100		$ (1,200)

REVENUE RECOGNITION, Contract L

REVENUE RECOGNITION, Contract Liabilities - Customer Loyalty Programs (Details) - USD ($) $ in Millions	Sep. 30, 2018	Dec. 31, 2017
Contract Liabilities - Customer Loyalty Programs [Abstract]
Contract liabilities for customer loyalty programs	$ 14.2	$ 13
Calculated under Cost Provision Methodology [Member]
Contract Liabilities - Customer Loyalty Programs [Abstract]
Contract liabilities for customer loyalty programs		1.9
Impact of Adopting ASC Topic 606 [Member]
Contract Liabilities - Customer Loyalty Programs [Abstract]
Contract liabilities for customer loyalty programs		$ 11.2